SEC 13F Intelligence

Vident Investment Advisory, LLC / ELV

Vident Investment Advisory, LLC’s Elevance Health Inc Formerly Position

Does Vident Investment Advisory, LLC own Elevance Health Inc Formerly (ELV)? Not currently — the last reported position was 31.7K shares worth $14M in Q2 2023; the fund’s latest 13F (Q3 2023) no longer reports it.

Position Value
$14M
Q2 2023
Shares
31.7K
% of Portfolio
+0.49%
Quarters Held
19
position exited

Position History ELV

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $3MQ2 ’19: $711,000Q3 ’19: $590,000Q3 ’19Q4 ’19: $3MQ1 ’20: $3MQ2 ’20: $4MQ2 ’20Q3 ’20: $4MQ4 ’20: $6MQ1 ’21: $7MQ1 ’21Q2 ’21: $4MQ3 ’21: $11MQ4 ’21: $15MQ4 ’21Q1 ’22: $17MQ2 ’22: $17MQ3 ’22: $14MQ3 ’22Q4 ’22: $17MQ1 ’23: $16MQ2 ’23: $14MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202331.7K$14M+0.49%
Q1 202335.0K$16M+0.52%
Q4 202232.8K$17M+0.63%
Q3 202232.8K$14M+0.47%
Q2 202235.1K$17M+0.51%
Q1 202234.8K$17M+0.44%
Q4 202131.3K$15M+0.38%
Q3 202130.1K$11M+0.34%
Q2 202110.9K$4M+0.13%
Q1 202120.6K$7M+0.25%
Q4 202017.4K$6M+0.23%
Q3 202015.6K$4M+0.21%
Q2 202013.8K$4M+0.19%
Q1 202013.4K$3M+0.19%
Q4 201910.5K$3M+0.20%
Q3 20192.5K$590,000+0.05%
Q2 20192.5K$711,000+0.06%
Q1 201911.9K$3M+0.18%
Q4 201816.2K$4M+0.24%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vident Investment Advisory, LLC’s full portfolio or all institutional holders of ELV.